Nixon Patel
About Nixon Patel
Data last updated:
Nixon Patel is a Director at Qcarbon Materials Private Limited (since 2024) and Director at Atri Pharma Research (India) Private Limited (since 2009). The companies operate in Pharma, Information Technology and FMCG. Earlier, Nixon Patel was a Director at Qulabs Software (India) Private Limited (2018–2024) and Director at Vivimed Labs Limited (2010–2019) and 11 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Qcarbon Materials Private Limited U72100TS2024PTC189211 | Director | 02 Dec 2024 | 2024 | Active | |
| Atri Pharma Research (India) Private Limited U73100TG2009PTC062684 | Director | 02 Feb 2009 | 2009 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Qulabs Software (India) Private Limited U72900TG2018PTC122439 | Director | 22 Feb 2018 | 2018 | ₹4.80 Cr (FY 2023) | Active |
 Vivimed Labs Limited L02411KA1988PLC009465 | Director | 28 Jun 2010 | 1988 | ₹121 Cr (FY 2025) | Active |
 Medisoft Telemedicine Private Limited U72200GJ2003PTC042760 | Director | 10 Mar 2009 | 2003 | Strike Off | |
 Axis Solutions Limited L43212GJ1985PLC029849 | Director | 20 Jul 2017 | 1985 | ₹45.54 Cr (FY 2020) | Active |
| Yantra Green Power Private Limited U40108TG2013PTC087049 | Director | 17 Apr 2013 | 2013 | ₹2.6 Lakh (FY 2024) | Active |
| Yantra Esolarindia Private Limited U40106GJ2010PTC149746 | Director | 11 Aug 2010 | 2010 | ₹16.05 Cr (FY 2021) | Active |
_PRIVATE_LIMITED.webp){kind=small} Bhrigus Software (India) Private Limited U72200TG2002PTC041721 | Director | 30 Oct 2002 | 2002 | Active | |
| Takshila Institute Of Renewable Energy Private Limited U40107TG2012PTC085180 | Director | 31 Dec 2012 | 2012 | Strike Off | |
 Kovid Group Analytics India Private Limited U72200TG2008PTC061210 | Director | 25 Sep 2008 | 2008 | ₹2.12 Cr (FY 2017) | Strike Off |
 Yantra Software Private Limited U72400TG2008PTC061186 | Director | 24 Sep 2008 | 2008 | Strike Off | |
| Kovid Research Labs India Private Limited U72900TG2017PTC117602 | Director | 06 Jun 2017 | 2017 | Strike Off | |
| Kovid Analytics Solutions India Private Limited U72900TG2017PTC117605 | Director | 06 Jun 2017 | 2017 | ₹25,715 (FY 2020) | Strike Off |
| Qulabz Ifsc Private Limited U67190GJ2023FTC138060 | Director | 04 Jan 2023 | 2023 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nixon Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Paras Shantilal Morabia | 08850172 | Qcarbon Materials Private Limited | Director |
| Santosh Varalwar | 00054763 | Atri Pharma Research (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nixon Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nixon Patel
Nixon Patel currently holds 2 directorships: Qcarbon Materials Private Limited (Director, since 02 Dec 2024); Atri Pharma Research (India) Private Limited (Director, since 02 Feb 2009).
Nixon Patel was first appointed on 30 Oct 2002 as Director at Bhrigus Software (India) Private Limited. The most recent appointment on record is 02 Dec 2024 at Qcarbon Materials Private Limited.
Nixon Patel held 13 earlier board appointments: Qulabs Software (India) Private Limited (Director, 22 Feb 2018 to 02 Sep 2024); Vivimed Labs Limited (Director, 28 Jun 2010 to 19 Dec 2019); Medisoft Telemedicine Private Limited (Director, 10 Mar 2009 to 01 Jul 2009); Axis Solutions Limited (Director, 20 Jul 2017 to 06 Apr 2019); Yantra Green Power Private Limited (Director, 17 Apr 2013 to 25 Aug 2017); and 8 more.
The current boards of Nixon Patel's companies include Paras Shantilal Morabia (Qcarbon Materials Private Limited), Santosh Varalwar (Atri Pharma Research (India) Private Limited).